platform to change the lives of patients with cancer Affimed is leading efforts to engage natural killer (NK) cells and macrophages to kill cancer cells. Having translated antibody engineering ...

A key question is, therefore, whether the immune suppressing macrophages can be converted to those attacking cancer to improve a patient's prognosis. Recently, Natural Killer (NK) cells have ...

Natural killer (NK) cells are cytotoxic, innate, lymphoid immune cells that can kill malignant cells without the need for HLA matching, making them appealing in the ever-growing cancer cell therapy ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

NK (natural killer) cells are a population of lymphocytes with both innate and adaptive immune features. They produce cytotoxic molecules and can eliminate infected cells or cancer cells.

subsequently killing the targeted cancer cells. 7 Meanwhile, additional innate immune effector cells – including macrophages, NK cells and gamma delta (γδ) T-cells – are activated to ...

Cord blood units for each cycle, used for the NK cells, were selected from the MD Anderson Cancer Center Cord Blood Bank and chosen based on the criteria previously identified for optimal cord ...

KAIST researchers isolated DDX54 as the master regulator that hinders the effectiveness of immunotherapy—opening a new path ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have ...

Cord blood units for each cycle, used for the NK cells, were selected from the MD Anderson Cancer Center Cord Blood Bank and chosen based on the criteria previously identified for optimal cord ...

Natural killer (NK) cells target infected and oncogenic cells, but are difficult to work with in vitro. Discover novel approaches to producing genetically modified NK cells for cell therapy.